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Background: The aim of this study was to examine the psychometric properties of the Fatigue Severity Scale (FSS)
to verify whether this instrument is a valid tool to measure fatigue in obese patients, and to examine the
prevalence of fatigue in obese patients.
Methods: Before and after a three-week residential multidisciplinary integrated weight reduction program, 220
patients were asked to fill in the questionnaires: FSS, Profile of Mood States (Fatigue-Inertia subscale, POMS-Fatigue,
and Vigor-Activity subscale, POMS-Vigor), and the Obesity-Related Well-Being (ORWELL-97). A subsample of 50
patients completed the questionnaire within two days.
Results: The prevalence of fatigue using a cut-off value of 4 for the FSS score was 59%. Correlations were found
between FSS and POMS-Fatigue and -Vigor scores (r = 0.58 and 0.53, respectively). A relation was also found
between FSS and ORWELL97 (r = 0.52, 0.42 to 0.61). From the factorial analysis only 1 factor was extracted
explaining 63% of variance, with factor loading values ranging from 0.71 (item 7) to 0.87 (item 6). Intraclass
Correlation Coefficient was 0.89 (0.82 to 0.94), while the agreement as measured using the Standard Error of
Measurement was 0.43 (0.36 to 0.54) corresponding to 13% (11 to 17%). Cronbach’s alpha values ranged from 0.94
to 0.93. The internal responsiveness of FSS was comparable to the ORWELL97 (Standardized Response Mean = 0.50
and 0.44, respectively).
Conclusions: Fatigue is an important and frequent symptom in obese patients and therefore should be routinely
assessed in both research and clinical practice. This can be achieved using the FSS, which is a short, simple, valid
and reliable tool for assessing and quantifying fatigue in obese patients.
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Fatigue is a symptom frequently reported in both healthy
[1] and several clinical populations such as patients with
depression, rheumatoid disorders, post stroke, multiple
sclerosis, mood disorders, psychiatric disturbances and
cancer [2]. Given the subjective nature of fatigue, no
exact definition exists. From a clinical point of view, fa-
tigue can be defined “as difficulty in initiation or sustain-
ing of voluntary activities” [2] and is characterized by
symptoms such as lack of energy, physical and mental
tiredness and apathy [2,3].
Fatigue has been associated with obesity in both adult
and pediatric populations and is a common complaint in* Correspondence: franco.impellizzeri@gmail.com
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distribution, and reproduction in any mediumobese people [4-6]. Furthermore, the use of fatigue as a
relevant outcome in intervention studies is increasing
[7,8]. Since fatigue perception is a subjective experience,
it can be measured using self-reports [2,6]. Among the
instruments used in obese population there are the
Multidimensional Fatigue Symptom Inventory [6], the
pediatric Quality of Life Inventory Multidimensional Fa-
tigue Scale [4] and the Fatigue Severity Scale (FSS) [7,8].
The FSS is one of the most commonly used fatigue
questionnaires in chronic diseases [9,10] and one of the
first instruments applied to obese people [11]. The FSS
is a short questionnaire developed by Krupp et al. [12]
and consists of 9 items that measure how fatigue affects
motivation, exercise, physical functioning, carrying out
duties, interfering with work, family, or social life. Given
it is a short and simple instrument, it can be implementedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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be easily added to other patient-reported outcome instru-
ments if additional specific aspects of quality of life would
like to be assessed by the researchers or practitioners.
Despite the potential usefulness of the FSS in obese
patients and the increased use of this tool for descriptive
and intervention studies [7,8], only the study by Grieve
et al. [11] has examined the suitability of this question-
naire in obese patients [11]. However, in that study the
cohort consisted of only females and few psychometric
properties were examined. The aim of this study was to
comprehensively examine the measurement properties
of the FSS to understand whether the FSS is a valid
tool for assessing and quantifying fatigue in obese pa-
tients. Specifically we sought to examine: 1) construct
validity (i.e. convergent, discriminant and structural
validity), 2) internal consistency and reproducibility
(reliability, agreement and minimal detectable change),




Two hundred and twenty consecutive obese subjects
participated in this prospective (pre-post) observational
study. Participants were inpatients referred to the
Division of Metabolic Diseases, Istituto Auxologico
Italiano, Piancavallo (Verbania, Italy) for a 3-week resi-
dential multidisciplinary integrated weight reduction
program entailing energy restricted diet, adapted phys-
ical activity, psychological and nutritional counseling.
Upon admission and after three weeks, patients were
asked to fill in the questionnaires. The intervention
lasted 3 weeks. As a consequence, while the absolute
level of responsiveness was not expected to be large in
absolute terms, the comparison with other question-
naires’ responsiveness was still possible and meaningful.
To examine absolute and relative reliability a subset of
50 consecutive patients at admission were asked to fill in
the questionnaires again after 48 hours. The study was
approved by the local Ethics Committee and all patients
provided written informed consent to participate.
Questionnaires
Fatigue severity scale
An Italian version of the FSS cross-cultural validated
according to available guidelines [13] was used. The FSS
consists of 9 statements for evaluating the impact of the
fatigue [12]. The subject was asked to rate the severity of
the fatigue symptoms experienced in the last week using
a numeric scale ranging from 1 (strong disagreement
with the statement) to 7 (strong agreement with the
statement). The total score has been calculated by aver-
aging the scores of each item.Profile of mood states
The POMS is a questionnaire consisting of 65 items for
evaluating six mood states [14] and each item is rated
on a 5-point Likert scale (scores from 1 to 5). For the
purpose of this study only the Fatigue-Inertia (POMS-
Fatigue) and Vigor-Activity (POMS-Vigor) scales were
used (for convergent and discriminant validity, respect-
ively). The summary scores of the two scales were calcu-
lated according to the developer instructions [14].
Obesity-related well-being (ORWELL-97)
The ORWELL 97 consists of 18 items measuring three
constructs: symptoms (five items), discomfort (seven
items), and impact (six items) [15,16]. For each item the
patient has to score, using a 4-point Likert scale, the oc-
currence and the severity of the symptom (occurrence)
and the relevance of the impairment caused by the spe-
cific symptom on daily-life (relevance). The score for
each item is calculated by multiplying occurrence by
relevance score with the higher values indicating a lower
condition. Although the single total values for occur-
rence (ORWELL 97-O) and relevance (ORWELL 97-R)
can be calculated in the present study, only the total
score was used.
Statistical analysis
Unless otherwise stated, all data are presented as the
mean and standard deviation (SD). Floor and ceiling ef-
fects were calculated as the percentage of patients show-
ing, respectively, the lowest and highest values for the
instrument. The lowest and highest values were also cal-
culated as the actual minimal and maximal scores for
the instruments plus or minus their corresponding
Minimal Detectable Change (MDC). This procedure was
applied to take into account the error of measurement
for the instrument.
Convergent and discriminant construct validity
To examine whether the FSS and POMS measured simi-
lar (convergent validity with POMS-Fatigue) or dissimi-
lar (discriminant validity with POMS-Vigor) constructs
and whether similar constructs changed to the same ex-
tent, we calculated the correlations (Pearson’s product
moment correlation coefficient) between the absolute
values and the change scores after the intervention. We
hypothesized a substantial (moderate) positive correl-
ation between FSS and POMS Fatigue, and a negative
correlation with POMS Vigor. Correlations were also
calculated between FSS and ORWELL-97.
The ability of the FSS to differentiate between patients
with a different amount of comorbidities, assuming that
those with more comorbidities were also those with
more fatigue symptoms, was examined using one-way
ANOVA with the factor “number of comorbidities”
Table 1 Baseline socio-demographic characteristics of the





Female N (% of total) 154 (70%) 36 (72%)
Male N (% of total) 66 (30%) 14 (28%)
Age Years (SD) 47 (15) 47 (12)
BMI kg/m2 44.4 (5.2) 44.5 (5.8)
Education Primary school 51% 50%
High school 39% 38%
University 10% 12%
Occupation White collars 22% 24%




Not employed 9% 10%
Other 1% -
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relations between FSS and BMI and age were also calcu-
lated using Pearson’s r.
Structural validity
Factor structure was examined using exploratory factor
analysis, with maximum likelihood factor extraction
method and oblique rotation (direct oblimin). The num-
ber of components were determined using the scree-test
on the sedimentation graph and the Kaiser’ s criterion,
which requires eigenvalues > 1 [17].
Reproducibility and internal consistency
Reliability was calculated using the intra-class correl-
ation coefficient (two-way mixed, single measure model)
while agreement was determined by calculating the
Standard Error of Measurement (SEM) [18]. The 95%
Confidence Interval for ICC and SEM was also reported.
The minimal detectable change (MDC) at the individual
level was calculated as SEM x √2 x 1.96. Systematic bias
was examined using a paired t-test. Data are presented
in absolute and relative (percentage) terms with percent-
ages calculated after log transformation. Internal
consistency was calculated using Cronbach’s alpha coef-
ficient (CA).
Internal responsiveness
We calculated internal responsiveness using the Cohen’s
d effect size [ES = (posttest mean – pretest mean)/SD
baseline] and standardized response mean [SRM= (post-
test mean – pretest mean)/SD changes][18-22]. The
confidence intervals (95%) for ES and SRM were also
calculated. Changes in the dependent variables were ana-
lyzed using a paired t-test and reporting the mean differ-
ence with the corresponding 95% confidence intervals.
The strength of the correlations were interpreted
using the Cohen’s benchmarks: <0.10, trivial; 0.10 to
0.30, small; 0.30 to 0.50, moderate; >0.50, large [23].
P values <0.05 were considered to be statistically signifi-
cant under the null-hypothesis paradigm. The analyses




The baseline socio-demographic characteristics of the
patients participating in the study are shown in Table 1.
The prevalence of fatigue using a cut-off value of 4 [3]
for the FSS score was 59%.
There were no missing data given the questionnaires
were filled under the control of operators. Only 3 pa-
tients reported at baseline the lowest FSS scale value
(floor effect) and 3 the highest value (ceiling effect).
Taking into account the MDC, the floor and ceilingeffect at baseline was 10%. Post-intervention, 7 subjects
reported the lowest value and only 1 the highest. Taking
into account the MDC, the floor and ceiling effect
post-intervention was 5%. The floor and ceiling effects
were lower than the 15% cut-off value considered ac-
ceptable [24,25].Evidence of construct validity
At baseline positive and large correlations were found
between FSS and POMS Fatigue score (r = 0.58; 95% CI
0.48 to 0.66). Similarly, the correlation between FSS and
POMS Vigor was significantly negative and moderate-
large (r = −0.53; 0.43 to 0.62). Similar figures were found
using the data collected post intervention (results not
shown). The correlation between the change scores
in FSS and POMS-Fatigue was positive and moderate
(r = 0.41, 0.29 to 0.51), while with POMS-Vigor the correl-
ation was negative and small (r = −0.26, 0.13 to 0.38).
Moderate-large correlations were also found between FSS
and ORWELL97 (r = 0.52, 0.42 to 0.61), while a small-
moderate correlation was found between change scores of
the two questionnaires (r = 0.29, 0.16 to 0.41).
Differences in FSS values (p < 0.001) were found for
groups of patients categorized according to the number
of comorbidities (Figure 1). A significant correlation was
found between age and FSS (r = 0.28, 0.15 to 0.40). The
correlation between FSS and BMI was significant but
small (r = 0.15, 0.02 to 0.28). However, when adjusted for
age the correlation increased to r = 0.25 (0.12 to 0.37).
From the factorial analysis only 1 factor was extracted
explaining 63% of variance, with factor loading values
ranging from 0.71 (item 7) to 0.87 (item 6).
Figure 1 Boxplots showing median (horizontal black line),
mean (dotted black line), interquartile range (box), error bar
(10th and 90th percentiles), and outliers (black circles) of the
FSS in obese patients classified according to the number
of comorbidities.
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No substantial systematic bias (mean difference: -0.2,
95% CI 0.0 to −0.4) was found between test [4.0 (SD
1.3)] and retest [3.8 (SD 1.3)] FSS values. Reliability as
measured using the ICC was 0.89 (0.82 to 0.94), while
the agreement as measured using the SEM was 0.43
(0.36 to 0.54) corresponding to 13% (11 to 17%). The
MDC was 1.2 points (37%). Cronbach’s alpha was 0.94
and 0.93 at baseline and post-intervention, respectively
(Table 2).
Internal responsiveness
Significant moderate changes were found for all the in-
struments and BMI after the three-week intervention
(Table 3). The internal responsiveness of FSS was com-




Cronbach's alpha if item deleted C
1 0.73 0.93 0
2 0.72 0.93 0
3 0.79 0.93 0
4 0.77 0.93 0
5 0.81 0.93 0
6 0.84 0.93 0
7 0.69 0.94 0
8 0.83 0.93 0
9 0.75 0.93 0Discussion
This study showed that the FSS is a valid instrument for
measuring fatigue in obese patients. The results of the
current investigation provided good evidence of validity
and reliability, suggesting this patient-reported outcome
tool is suitable for both cross-sectional and longitudinal
assessments of fatigue in both practice and research
settings.
Construct validity
To build up a body of evidence to support the validity of
a measure, several attributes should be examined
[26,27]. In the present study, we examined the conver-
gent validity of the FSS with the POMS-Fatigue score as
it is supposed to measure the same construct. The cor-
relation was significant and close or higher than the 0.50
cut-off correlation value considered the minimum for
showing adequate construct validity. However, the lower
limit of the confidence intervals was below this cut-off
value and a correlation of 0.50 means that only 25% of
the variance is shared. Therefore, although the two in-
struments measured a similar construct, they probably
assessed different aspects of fatigue. Indeed, while the
POMS-Fatigue scale has been suggested to be a measure
of the fatigue severity, the FSS is considered a measure
of both severity and impact of fatigue on daily life [10].
We also examined the discriminant validity (ability to
discriminate dissimilar constructs) by assessing the
relation between FSS and POMS-Vigor score, which we
hypothesized, would go in the opposite direction.
According to our theory, the relation between FSS and
POMS-Vigor was negative. Moderate correlations were
also found between the change scores of the FSS and
POMS scales further confirming the two instruments
measured similar constructs. The correlations between
change scores can also be interpreted as evidence (mod-
erate) of external responsiveness that has been defined
as the ability of a questionnaire to detect change overe Severity Scale
fter intervention










Table 3 Internal responsiveness and pre-post changes of the various patient-reported outcomes
Pre Post Pre-post difference ES (d) SRM
Mean (SD) Mean (SD) Value (95% CI) Value (95%CI) Value (95%CI)
BMI 44.2 (5.2) 42.7 (6.0) −1.6 (−1.1 to −2.0) −0.31 (−0.03 to −0.58) −0.53 (−0.25 to −0.80)
ORWELL-97 51.5 (27.9) 43.0 (27.0) −8.4 (−5.7 to −11.1) 0.30 (−0.03 to −0.57) −0.44 (−0.17 to −0.72)
FSS Total score 3.9 (1.3) 3.4 (1.3) −0.5 (−0.4 to −0.7) −0.37 (−0.10 to −0.65) −0.50 (−0.22 to −0.78)
POMS-Fatigue 9.2 (5.7) 6.5 (5.4) −2.7 (−2.0 to −3.3) −0.47 (−0.20 to −0.75) −0.55 (−0.27 to −0.83)
POMS-Vigor 14.9 (6.9) 17.3 (6.9) 2.3 (1.6 to 3.1) 0.33 (0.06 to 0.61) 0.42 (0.14 to 0.69)
Impellizzeri et al. Health and Quality of Life Outcomes 2013, 11:32 Page 5 of 7
http://www.hqlo.com/content/11/1/32time in the construct to be measured [10,24]. However,
since there are no reference measures for assessing fa-
tigue in obese population, we prefer to consider this
finding a further evidence of convergent construct valid-
ity. As further evidence of construct validity we com-
pared the FSS scores of obese patients concurrently
experiencing other comorbidities, therefore assuming
that the more the comorbidities the higher the level of
fatigue. As hypothesized, we found that the level of fa-
tigue increased with the number of comorbidities. Lastly,
the factor analysis confirmed the 1-factor structure of
the FSS, explaining 63% of the variance, which is a value
higher than the 0.50 cut-off considered necessary for
confirming the structure validity [10,24]. The amount of
variance explained found in the present study is similar
to the 67.7% recently reported by Ferentinos et al. in pa-
tients with major depression [28]. Overall, the aforemen-
tioned findings support the construct validity of the FSS
as measure of fatigue in obese patients.
Reproducibility and internal consistency
When exploring the reproducibility of an instrument
both reliability and agreement should be determined
[18]. The reliability of the FSS as measured using the
ICC was 0.89, which is usually considered a high value
and thus suggesting the FSS is potentially an adequate
instrument for cross-sectional comparisons. The agree-
ment (measurement error) as measured using the SEM
was 0.4 corresponding to 13% of the mean FSS values.
Based on this SEM, the MDC (with 95%CI) was 1.2
points (37%) meaning that individual changes higher
than these figures can be interpreted as real and not due
to measurement error with an acceptable probability
level. The SEM and MDC reported can be used for
helping to appropriately interpret the changes in the
practical setting. Overall, the reproducibility was found
to be good and adequate to use the FSS for both differ-
entiating between individuals and for longitudinal
assessments.
Similar to previous studies, the FSS showed excellent
internal consistency [3,10]. Valko et al.[3] reported in pa-
tients with various disorders usually associated to fa-
tigue, the lowest internal consistency for items 1 and 2.
Our analysis showed the lowest values for items 1,2 and 7both before and after the three-week intervention. There-
fore, our results are partly in agreement with Valko et al.
[3]. In a series of recent studies examining the psychomet-
ric properties of the FSS using Item Response Theory in
stroke, multiple sclerosis and HIV-infected adults, high
mean square values were found for items 1 and 2, and a
reduced version (FFS-7) has been proposed [29-31]. The
results of these previous studies and our findings seems to
suggest that further studies using classical and/or modern
test theory are probably needed to understand whether a
reduced version may show even better measurement
properties for use in obese patients.
Internal responsiveness
After the three-week intervention the scores of the
patient-reported outcomes improved significantly. The
responsiveness as measured using ES ranged from 0.30
to 0.47 and from 0.42 to 0.55 for SRM. Overall, these
figures indicated that the entity of improvements after
the intervention was moderate which was not surpris-
ingly given the short duration of the intervention that
aimed to provide the foundations for future changes.
However, the main purpose was to compare the internal
responsiveness of the FSS with the other instruments
and particularly with disease-specific questionnaires that
are usually responsive. The results showed that the ES
and SRM values of the FSS were comparable with those
found for the ORWELL97, which is a specific instru-
ment developed for assessing obesity-related quality of
life taking into account both the intensity and the sub-
jective relevance of physical and psychosocial distress
[15,16]. A significant correlation was also found between
absolute and change scores of the FSS and ORWELL97.
Since ORWELL97 measures a different construct than
fatigue, we interpreted the significant correlation as the
confirmation of the association between fatigue percep-
tion and health-related quality of life of obese patients.
Therefore, the FSS may be a complementary tool to
other specific instruments that are used to evaluate
other aspects of health-related quality of life.
Fatigue in obese patients
The prevalence of fatigue in this cohort of 220 patients
using 4 as cut-off value [3] was 59%. This figure is
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(58%), stroke patients (49%), and patients with sleep-
wake disorders (62%) [3,32]. Although in other clinical
populations the prevalence of fatigue is higher (e.g. mul-
tiple sclerosis [3,33]), the figure found in the current
study confirms that fatigue is a relevant symptom in this
population and as a consequence should be assessed
more frequently. Although fatigue is a common symp-
tom in several diseases and chronic conditions including
obesity, it is quite surprising that fatigue was not in-
cluded as a separate category in the International Classi-
fication of Functioning, Disability and Health (ICF) [34]
as also remarked by Newman [35]. However, the dimen-
sion/trait “fatigue” is addressed by the ICF category b130
(“energy and drive functions”) [36], which is one of the 9
categories selected and included by a panel of inter-
national experts in the Brief ICF core set for obesity
[37]. This further confirms the clinical importance of
assessing fatigue in obese patients. Lastly, fatigue not
only influences the quality of life but may be an add-
itional factor contributing to the exacerbation of the
obese condition. As suggested for cancer patients (for
which fatigue is a severe symptom) and more recently
for obese too [6,38], fatigue may reduce the level of
physical activity making it more difficult to counteract
the fatigue itself and the weight management. Therefore,
fatigue can create a vicious cycle and a self-perpetuating
condition. This area certainly necessitates future studies.Limitations
Although the approach used in this study for examining
the psychometric properties of the FSS is traditional and
well established, other methods such as Item Response
Theory are warranted for further confirming the validity
of the FSS in obese patients. Furthermore, the FSS meas-
urement properties found in the present cohort cannot
be automatically extended to obese patients undergoing
other treatments such as bariatric surgery, especially in
relation to the sensitivity to changes. While promising,
other studies are necessary to provide more evidence of
validity of the FSS in obese population and for better
interpreting the results (e.g. minimal clinically important
changes).Conclusion
In conclusion, fatigue is an important and frequent
symptom in obese patients affecting quality of life, which
may also influence weight management. The FSS is a
short, simple, valid and reliable tool for assessing and
quantifying fatigue in obese patients. For these reasons,
the FSS can and should be used more frequently in both
clinical practice and research. Further studies examining
the impact of fatigue on obesity and how to manage thissymptom for its potential role as a mediator in obesity
treatments are warranted.
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